Members of the multidrug resistance-associated protein (MRP) family of transporters are believed to contribute to cytotoxic drug resistance and chemotherapy failure. We observed frequent MRP4 overexpression in aggressive primary neuroblastoma, a disease for which we have previously shown MRP1 to be a prognostic indicator. High MRP4 expression correlated with MYCN oncogene amplification and was significantly associated with poor clinical outcome. Although MRP4 is known to transport some nucleoside analogues, it has not previously been associated with resistance to drugs used to treat solid tumors. We now show that it mediates substantial resistance in vitro to the topoisomerase I poison irinotecan/CPT-11 and its active metabolite SN-38. These results suggest that MRP4 will be a useful prognostic marker for neuroblastoma and that clinical trials of irinotecan as a neuroblastoma treatment should monitor MRP4 expression. The same may be true for other tumor types expressing high levels of the transporter.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1158/1535-7163.MCT-04-0161 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Investigating the crosstalk between and in 3T3-L1 adipocyte differentiation.
Front Mol Biosci
December 2024
Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, United States.
Introduction: The plasma membrane-bound protein, multi-drug resistance-associated protein 4 (), has gained attention for its pivotal role in facilitating the efflux of a wide range of endogenous and xenobiotic molecules. Its significance in adipogenesis and fatty acid metabolism has been brought to light by recent studies. Notably, research on knockout ( ) mice has established a link between the absence of and the development of obesity and diabetes.
View Article and Find Full Text PDFUpregulation of P-Glycoprotein and Breast Cancer Resistance Protein Activity in Newly Developed in Vitro Rat Blood-Brain Barrier Spheroids Using Advanced Glycation End-Products.
Biol Pharm Bull
November 2024
Department of Pharmaceutics, Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama.
The blood-brain barrier (BBB) is a dynamic interface controlling the compound translocation between the blood and the brain, thereby maintaining neural homeostasis. There is cumulative evidence that BBB impairment during diabetes mellitus (DM) takes part in the progression of cognitive dementia. As tight junction proteins and ATP-binding cassette (ABC) transporters regulate substance exchange between the circulating blood and brain, the expression and function of these molecules under DM should be fully clarified.
View Article and Find Full Text PDFEnhanced platelet sensitization is accompanied by increased expression of the transporter MRP4 and elevated plasma S1P levels in mild COVID-19 convalescents.
Platelets
December 2024
Department Pharmacology and Toxicology, University Medicine Oldenburg, Carl von Ossietzky University Oldenburg, Oldenburg, Germany.
Viral infections can lead to platelet activation and hemostatic complications. However, the extent to which platelet reactivity remains altered after convalescence, contributing to long-term health impairments as observed after COVID-19 is not yet fully understood. Therefore, we conducted a cohort study (DRKS00025217) to determine platelet function in individuals convalesced from mild COVID-19.
View Article and Find Full Text PDFAbsolute Membrane Protein Abundance of P-gp, BCRP and MRPs in Term Human Placenta Tissue and Commonly Used Cell Systems: Application in PBPK Modeling of Placental Drug Disposition.
Drug Metab Dispos
October 2024
Systems Pharmacology, Manchester Pharmacy School, University of Manchester, United Kingdom.
Article Synopsis
- The study focuses on the role of the placenta in drug transport and nutrient transfer, identifying key transporters in human placenta and various cell lines.
- Researchers found significant expression levels of transporters like P-gp, BCRP, MRP2, MRP4, and MRP6, with some notable differences between tissue and cell line models.
- The findings suggest that proteomic analysis combined with a physiologically-based pharmacokinetic (PBPK) model can accurately predict fetal drug exposure and offers a standardized approach for future studies on maternal and fetal drug interactions.
Dietary protein intake and the tubular handling of indoxyl sulfate.
Nephrol Dial Transplant
October 2024
Department of Microbiology, Immunology and Transplantation, Nephrology and Renal Transplantation Research Group, KU Leuven, Leuven, Belgium.
Background And Hypothesis: Chronic kidney disease (CKD) patients are advised to limit their protein intake. A high protein diet is known to induce glomerular hyperfiltration, as well as hypertrophy of the remnant kidney, and glomerulosclerosis. Whether the diet causes changes in kidney tubule transport via gut microbiome metabolites is still unknown.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!